Literature DB >> 11163769

Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding.

C S Hampe1, L P Hammerle, A Falorni, J Robertson, A Lernmark.   

Abstract

The role of K396 in the enzymatic catalysis and the antigenicity of the 65 kDa isoform of glutamate decarboxylase (GAD65) was analyzed using the K396R GAD65 mutant. GAD65 is a major autoantigen in Type 1 diabetes and autoantibodies directed to GAD65 are widely used markers for this disease. We found that (1) recombinant human GAD65 is fully enzymatically active; (2) the K396R mutation abolished GAD65 activity; and (3) the K396R mutant retained full antigenicity to GAD65 autoantibodies in serum from Type 1 diabetes patients, but not to polyclonal antibodies raised to the catalytic domain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163769     DOI: 10.1016/s0014-5793(00)02429-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.

Authors:  Esther Ganelin-Cohen; Dalit Modan-Moses; Rina Hemi; Hannah Kanety; Bruria Ben-Zeev; Christiane S Hampe
Journal:  Pediatr Diabetes       Date:  2015-12-29       Impact factor: 4.866

2.  A comparative analysis of recombinant protein expression in different biofactories: bacteria, insect cells and plant systems.

Authors:  Elisa Gecchele; Matilde Merlin; Annalisa Brozzetti; Alberto Falorni; Mario Pezzotti; Linda Avesani
Journal:  J Vis Exp       Date:  2015-03-23       Impact factor: 1.355

3.  Stability of Potato virus X expression vectors is related to insert size: implications for replication models and risk assessment.

Authors:  Linda Avesani; Giampiero Marconi; Francesca Morandini; Emidio Albertini; Matteo Bruschetta; Luisa Bortesi; Mario Pezzotti; Andrea Porceddu
Journal:  Transgenic Res       Date:  2007-01-11       Impact factor: 2.788

4.  Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.

Authors:  Marta Rizzi; Rolf Knoth; Christiane S Hampe; Peter Lorenz; Marie-Lise Gougeon; Brigitte Lemercier; Nils Venhoff; Francesca Ferrera; Ulrich Salzer; Hans-Jürgen Thiesen; Hans-Hartmut Peter; Ulrich A Walker; Hermann Eibel
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

5.  High titers of autoantibodies to glutamate decarboxylase in type 1 diabetes patients: epitope analysis and inhibition of enzyme activity.

Authors:  Christiane S Hampe; Murray E Maitland; Lisa K Gilliam; Thanh-H Thi Phan; Ian R Sweet; Jared R Radtke; Vasile Bota; Bruce R Ransom; Irl B Hirsch
Journal:  Endocr Pract       Date:  2013 Jul-Aug       Impact factor: 3.443

6.  Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.

Authors:  Mario U Manto; Christiane S Hampe; Véronique Rogemond; Jérome Honnorat
Journal:  Orphanet J Rare Dis       Date:  2011-02-04       Impact factor: 4.123

7.  Comparative analysis of different biofactories for the production of a major diabetes autoantigen.

Authors:  Linda Avesani; Matilde Merlin; Elisa Gecchele; Stefano Capaldi; Annalisa Brozzetti; Alberto Falorni; Mario Pezzotti
Journal:  Transgenic Res       Date:  2013-10-20       Impact factor: 2.788

8.  GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Authors:  Suvi Liimatainen; Jerome Honnorat; Sean J Pittock; Andrew McKeon; Mario Manto; Jared R Radtke; Christiane S Hampe
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.